Dergiler / Marmara Medical Journal / 2022 / Cilt: 35 - Sayı: 3

Vitamin D receptor gene polymorphisms in pediatric patients with leukemia-lymphoma: Does it have an impact on malignancy?

Sayfa
270–274
Yayın Tarihi
2022-10-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Contrary to most publications in the literature, polymorphisms were not found to be risk factors in our study.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Genetic variations have been identified in specific regions of the Vitamin D receptor (VDR) gene and many studies were investigating whether these variations are associated with malignancy.
📊
Temel Bulgular & Veri:Patients and Methods: Of the 99 participants included in this cross-sectional study, 59 were control, 40 were patients.
💡
Sonuç & Katkı:Contrary to most publications in the literature, polymorphisms were not found to be risk factors in our study.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Childhood cancers · Leukemia · Lymphoma

Abstract

Objective: Genetic variations have been identified in specific regions of the Vitamin D receptor (VDR) gene and many studies were investigating whether these variations are associated with malignancy. Studies in the VDR on children are scarce. In this study, we aimed to investigate the VDR gene polymorphisms in pediatric patients with the diagnosis of leukemia and lymphoma. Patients and Methods: Of the 99 participants included in this cross-sectional study, 59 were control, 40 were patients. Fok-I, Bsm-I and Taq-I polymorphism of the VDR gene were investigated in both groups. Results: While no significant difference was found in the genotype distribution of the three polymorphisms between the patient and control groups, significant results were obtained in Bsm-I and Taq-I allele frequencies (Odds ratio=0.489; CI95%=0.275-0.871 and 0.519; CI95%=0.280-0.964) (p<0.05). Conclusions: In this study, we found that the frequency of allele “A” for Bsm-I and allele “C” for Taq-I was lower in the patient group. Contrary to most publications in the literature, polymorphisms were not found to be risk factors in our study.

🔖

Bu Makaleye Atıf Yap

KERSIN, S. G., TOKUC, A. G., ARMAN, A., YILMAZ, B. (2022). Vitamin D receptor gene polymorphisms in pediatric patients with leukemia-lymphoma: Does it have an impact on malignancy?. Marmara Medical Journal, Cilt: 35 - Sayı: 3, 270–274. https://ajindex.com/articles/688227

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021
  2. doi: 10.3322/caac.21654. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010
  3. b5664. doi:10.1136/bmj. b5664 Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007
  4. doi:10.1038/nrc2196 Köstner K, Denzer N, Muller CSL, Klein R, Tilgen W, Reichranth J. The Relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: A review of the literature. Anticancer Res 2009
  5. PMID: 19667145. Raimondi S, Harriet Johansson H, Patrick Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009
  6. doi: 10.1093/carcin/bgp103. Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc 2008
  7. doi: 10.1017/S002.966.5108006964. Beysel S, Eyerci N, Pinarli FA, et al. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer. Tumour Biol 2018
  8. 8318811766. doi: 10.1177/101.042.8318811766. Yu ZH, Chen M, Zhang QQ, Hu X. The association of vitamin D receptor gene polymorphism with lung cancer risk: An update meta-analysis. Comb Chem High Throughput Screen 2018
  9. doi: 10.2174/138.620.7322666.190.12515055 7. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: The Rancho Bernardo Study. Metabolism 2002
  10. 356–9. doi: 10.1053/ meta.2002.29969. Rasool S, Kadla SA, Rasool V, et al. Role of the VDR Bsm1 and Apa1 polymorphisms in the risk of colorectal cancer in Kashmir. Oncol Res Treat 2014
  11. doi: 10.1159/000362859. Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 2001
  12. doi: 10.1054/bjoc.2001.1864. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Colston KW. Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk. Recent Results Cancer Res 2003
  13. doi: 10.1007/978-3-642- 55580-0_3. Zhang K, Song L. Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies. PLoS One 2014
  14. e96125. doi: 10.1371/journal. pone.0096125. Luo S, Guo L, Li Y, Wang S. Vita